Results 101 to 110 of about 202,439 (195)

Exploring EBNA3C Genetic Variability and Recombination in Epstein-Barr Virus-Associated Cancers. [PDF]

Int J Mol Sci
Barra A, Vasquez-Aguilar P, Braz-Silva PH, Zanella L.   +3 more
europepmc   +1 more source

A System-Level Perspective on Epstein-Barr Virus Persistence: The Partial Lytic Reactivation. [PDF]

Int J Mol Sci
Michalak KP, Adamski W.
europepmc   +1 more source

"Bilateral Nigral Hyperintensity Sign" in Epstein-Barr Virus Encephalitis. [PDF]

J Glob Infect Dis
Naaz S, Madduluri B, Turaga SP, Balam Y, Siddaiah A.   +4 more
europepmc   +1 more source

Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood: A Case Series. [PDF]

Pediatr Blood Cancer
Zarrabi M, Cahaney C, Schwartz LF, Kovach AE, Lin C, Stokke J.   +5 more
europepmc   +1 more source

Epstein-Barr Virus-Associated T/NK-Cell Neoplasms. [PDF]

J Med Virol
Sato Y, Okuno Y, Murata T, Kimura H.
europepmc   +1 more source

Epstein-Barr virus infection in children with liver transplantation. [PDF]

World J Hepatol
Onpoaree N, Leelakanok N, Sanpavat A, Sintusek P.   +3 more
europepmc   +1 more source

The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus. [PDF]

Hum Vaccin Immunother
Akingbola A, Idahor C, Adegbesan A, Fakiyesi T, Aikulola O, Tundealao S, Mariaria P.   +6 more
europepmc   +1 more source

Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitis. [PDF]

Front Immunol
Chapuis AG, Orozco JJ, Milano F.
europepmc   +1 more source

Targeting Epstein-Barr virus is a viable therapeutic strategy in multiple sclerosis: Commentary. [PDF]

Mult Scler
Hedström AK.
europepmc   +1 more source

Epstein-Barr Virus and Hepatitis E Virus in an Immunocompetent Adult: A Rare Case Report. [PDF]

Clin Case Rep
Attieh P, Al Hazzouri A, Karam K, El Hajj II, Fiani E.   +4 more
europepmc   +1 more source